
|Videos|July 12, 2020
Glaucoma 360: Accessible glaucoma care in 1 second (BELKIN Laser)
Author(s)Alex Delaney-Gesing
ICYMI: Daria Lemann Blumenthal, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT).
Advertisement
ICYMI: Daria Lemann Blumenthal, LLB, EMBA, CEO of BELKIN Laser, Ltd., discusses the company's current initiative of developing an automated one-second laser therapy for glaucoma called direct selective laser trabeculoplasty (DSLT), during the 2020 Glaucoma 360 meeting in San Francisco, California.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Q&A: What’s in the glaucoma treatment pipeline?
2
SpyGlass Pharma randomizes first patients in 2 phase 3 clinical trials of the BIM-IOL System
3
Moorfields study reveals sharp rise in glaucoma burden across the UK
4
Why individualized glaucoma care remains essential amid uneven patient awareness
5



























